Finance

Beta
Lists
003020:SHE
Hefei Lifeon Pharmaceutical Co Ltd
CNÂ¥15.52
+1.37%
(+0.21) 1D
Jun 12, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003020...
Open
CNÂ¥15.40
High
CNÂ¥15.58
Low
CNÂ¥15.13
Mkt. cap
3.54B
Avg. vol.
2.12M
Volume
1.79M
Dividend
2.68%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
21.85
52-wk high
CNÂ¥34.56
52-wk low
CNÂ¥15.11
EPS
CNÂ¥0.71
Shares outstanding
228.22M
No. of employees
1K
Open
CNÂ¥15.40
High
CNÂ¥15.58
Low
CNÂ¥15.13
Mkt. cap
3.54B
Avg. vol.
2.12M
Volume
1.79M
Dividend
2.68%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
21.85
52-wk high
CNÂ¥34.56
52-wk low
CNÂ¥15.11
EPS
CNÂ¥0.71
Shares outstanding
228.22M
No. of employees
1K
News stories
From sources across the web
About Hefei Lifeon Pharmaceutical Co Ltd
CEO-
Employees1.46K
FoundedJul 16, 2002
Headquarters-
SectorPharmaceutical industry
Websitelifeon.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
372.21M
348.25M
473.12M
357.10M
Cost of goods sold
137.20M
112.98M
179.98M
121.91M
Cost of revenue
137.20M
112.98M
179.98M
121.91M
Research and development expenses
32.51M
19.45M
39.36M
18.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169.06M
171.75M
215.72M
170.83M
Operating expense
205.90M
195.72M
262.92M
193.88M
Total operating expenses
343.10M
308.69M
442.90M
315.80M
Operating income
29.10M
39.55M
30.22M
41.30M
Other non operating income
65.48K
-544.58K
604.09K
-537.41K
EBT including unusual items
56.71M
35.98M
44.93M
41.31M
EBT excluding unusual items
51.80M
40.71M
30.20M
40.63M
Income tax expense
4.46M
4.40M
4.49M
6.05M
Effective tax rate
7.86%
12.23%
10.00%
14.65%
Other operating expenses
4.04M
5.15M
7.85M
4.63M
Net income
51.98M
30.71M
44.25M
35.29M
Net profit margin
13.96%
8.82%
9.35%
9.88%
Earnings per share
-
-
-
-
Interest and investment income
23.77M
1.69M
692.37K
264.54K
Interest expense
-1.14M
-
-1.26M
-399.14K
Net interest expenses
22.63M
1.69M
-564.11K
-134.59K
Depreciation and amortization charges
-
-
-
-
EBITDA
49.64M
58.28M
51.18M
62.27M
Gain or loss from assets sale
-1.77K
1.77K
1.68K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more